Doxorubicin and edelfosine lipid nanoparticles are effective acting synergistically against drug-resistant osteosarcoma cancer cells

  1. González-Fernández, Y.
  2. Imbuluzqueta, E.
  3. Zalacain, M.
  4. Mollinedo, F.
  5. Patiño-García, A.
  6. Blanco-Prieto, M.J.
Journal:
Cancer Letters

ISSN: 1872-7980,  0304-3835

Year of publication: 2017

Volume: 388

Pages: 262-268

Type: Article

DOI: 10.1016/J.CANLET.2016.12.012 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus